Varani Michela, Auletta Sveva, Signore Alberto, Galli Filippo
Nuclear Medicine Unit, Department of Medical-Surgical Sciences and of Translational Medicine, Faculty of Medicine and Psychology, "Sapienza" University of Rome, 00161 Rome, Italy.
Cancers (Basel). 2019 Jul 9;11(7):967. doi: 10.3390/cancers11070967.
Natural killer (NK) cell therapy is a promising alternative to conventional T cell-based treatments, although there is a lack of diagnostic tools to predict and evaluate therapeutic outcomes. Molecular imaging can offer several approaches to non-invasively address this issue. In this study, we systematically reviewed the literature to evaluate the state of the art of NK cell imaging and its translational potential. PubMed and Scopus databases were searched for published articles on the imaging of NK cells in humans and preclinical models. Study quality was evaluated following Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) criteria. We pooled studies as follows: Optical, magnetic resonance imaging (MRI) and nuclear medicine imaging with a total of 21 studies ( = 5, = 8 and = 8, respectively). Considering the limitation of comparing different imaging modalities, it appears that optical imaging (OI) of NK cells is very useful in a preclinical setting, but has the least translational potential. MRI provides high quality images without ionizing radiations with lower sensitivity. Nuclear medicine is the only imaging technique that has been applied in humans (four papers), but results were not outstanding due to a limited number of enrolled patients. At present, no technique emerged as superior over the others and more standardization is required in conducting human and animal studies.
自然杀伤(NK)细胞疗法是传统基于T细胞治疗的一种有前景的替代方法,尽管缺乏预测和评估治疗结果的诊断工具。分子成像可以提供几种非侵入性解决这一问题的方法。在本研究中,我们系统回顾了文献,以评估NK细胞成像的现状及其转化潜力。在PubMed和Scopus数据库中搜索关于人类和临床前模型中NK细胞成像的已发表文章。按照诊断准确性研究质量评估(QUADAS-2)标准评估研究质量。我们将研究汇总如下:光学成像、磁共振成像(MRI)和核医学成像,共有21项研究(分别为5项、8项和8项)。考虑到比较不同成像方式的局限性,似乎NK细胞的光学成像(OI)在临床前环境中非常有用,但转化潜力最小。MRI能提供高质量图像且无电离辐射,但灵敏度较低。核医学是唯一已应用于人类的成像技术(4篇论文),但由于入组患者数量有限,结果并不突出。目前,没有一种技术比其他技术更具优势,在进行人类和动物研究时需要更多的标准化。